Single Rising Dose Study of BI 201335 ZW in Healthy Male Subjects

NCT02182271 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 201335 ZW - single rising dose
DRUG: Placebo

Sponsor

Boehringer Ingelheim